MichaelAaron Flicker, founder and CEO of XenoPsi Ventures, walks through the impact that GLP-1 drugs are having on consumer behavior and how some of the top consumer food brands are responding. Flicker examines how GLP-1 users impact the behavior of entire households, the changing dynamic of the restaurant experience and where GLP-1 users are spending outside of grocery stores and eating out. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

MichaelAaron Flicker on How GLP-1s Change Food Industry & Household Dynamics

Schwab Network

[SPEAKER_02] Welcome to Market Matters. I'm Marlee Caden. This is episode 20 and today we are looking beyond the medical headlines of GLP-1 agonists to examine what may be one of the most significant consumer behavior re-engineering events of our generation. We know these drugs regulate blood sugar and suppress appetite, but as adoption accelerates, the ripple effects are extending far beyond the individual patients.

[SPEAKER_01] 13 out of 20 were thinking about food noise interrupting their daily routine drops to 6 out of 20, a 54% decline. And what that shows us is the mental state of how people approach buying, approach consuming is really changing.

[SPEAKER_02] Joining us today is MichaelAaron Flicker, the founder of Method One, president of Xenosci Ventures and co-author of Hacking the Human Mind. MichaelAaron sits at the direct intersection of behavioral science, brands and business, studying not just what consumers say they will do, but what they actually do when their underlying psychology and biology shifts.

[SPEAKER_02] MichaelAaron, welcome to the podcast. I've really been looking forward to this. We find a lot of our guests in our TV interviews and we talked all about GLP-1s and I've been waiting to dive in. My love of this space and adoption is no secret. But before we get into the specifics about what GLP-1s do to individual psychology and biology, let's talk macro first.

[SPEAKER_02] We've watched usage expand so rapidly. The latest data says nearly one in eight Americans are currently taking a GLP-1. It's higher if you look at people who have taken them. When a consumer shift hits this level of critical mass so quickly, how do you categorize it from a behavioral science perspective? Is this a standard health and wellness trend? Is that what we're looking at?

MichaelAaron Flicker on How GLP-1s Change Food Industry & Household Dynamics

Read the full transcript

The candid version is on a podcast,
not the earnings call.

MichaelAaron Flicker on How GLP-1s Change Food Industry & Household Dynamics

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.